Drug Shortage Report for TARO-TESTOSTERONE
Report ID | 178080 |
Drug Identification Number | 02421186 |
Brand name | TARO-TESTOSTERONE |
Common or Proper name | TESTOSTERONE |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | TESTOSTERONE UNDECANOATE |
Strength(s) | 40MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 12 x 10 |
ATC code | G03BA |
ATC description | ANDROGENS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-11-28 |
Estimated end date | 2023-09-01 |
Actual end date | 2023-09-01 |
Shortage status | Resolved |
Updated date | 2023-09-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v30 | 2023-09-22 | French | Compare |
v29 | 2023-09-22 | English | Compare |
v28 | 2023-08-16 | French | Compare |
v27 | 2023-08-16 | English | Compare |
v26 | 2023-07-18 | French | Compare |
v25 | 2023-07-18 | English | Compare |
v24 | 2023-06-09 | French | Compare |
v23 | 2023-06-09 | English | Compare |
v22 | 2023-05-15 | French | Compare |
v21 | 2023-05-15 | English | Compare |
v20 | 2023-05-08 | French | Compare |
v19 | 2023-05-08 | English | Compare |
v18 | 2023-04-28 | French | Compare |
v17 | 2023-04-28 | English | Compare |
v16 | 2023-04-10 | French | Compare |
v15 | 2023-04-10 | English | Compare |
v14 | 2023-03-24 | French | Compare |
v13 | 2023-03-24 | English | Compare |
v12 | 2023-03-10 | French | Compare |
v11 | 2023-03-10 | English | Compare |